September 09, 2020

Chinese Biotech Sector is Blowing Hot as M&A and IPO Deals Surge Amid Covid-19 Pandemic

Toto Ku, Datasite Senior Sales Director, provides comments on the outlook for the Chinese biotech sector, including the surge in M&A and IPO deals amid the COVID-19 pandemic. The South Morning China Post article highlights findings from a recent webinar discussion on Deal Drivers in the Healthcare and Life Sciences: Mainland China.

  • Datasite for Healthcare

    Navigating the healthcare and life sciences industry has never been harder. Whether you’re looking at a licensing, listing or M&A, achieve your objective quickly and keep sensitive data secure with Datasite.

Contacts

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

[email protected]

Investor Relations
Jennifer Percy

Senior Vice President, Finance & Treasury

651.632.4009

[email protected]

You may also like:

3 Ways to Create a More Connected Workplace

CHRO Deb LaMere writes about ways leaders can create a more connected workplace in the new world of hybrid work.

Smash the Employee Culture Clash to Ensure Value Creation in M&A

GC Patty Elias writes about how to mitigate cultural differences between combining companies, even before the deal is complete.

Law.com
3 Retail Deals That Went Awry This Year

Americas CRO Mark Williams comments on retail M&A this year and its outlook for the future.